Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (102 total)
-
![CDC Vesicular-Pustular rash-illness-protocol_Dec 2016[12].pdf](https://repository.netecweb.org/files/square_thumbnails/81a40a91cbdb605360f506c4df5e9a3c.jpg "CDC Vesicular-Pustular rash-illness-protocol_Dec 2016[12].pdf")
Creator: CDC
Subject: Laboratory
Item Type: Protocol
Date Last Updated: 2016-12-01
Description: This protocol has been developed to guide the sequence and type of laboratory testing to be undertaken in situations involving specimens from patients with acute, generalized vesicular or pustular rash illness, or suspected smallpox vaccine (vaccinia… -
Creator: Dugdale, C. M., M. N. Anahtar, J. J. Chiosi, J. E. Lazarus, S. M. McCluskey, A. L. Ciaranello, T. Gogakos, B. P. Little, J. A. Branda, E. S. Shenoy, R. P. Walensky, K. C. Zachary, D. C. Hooper, S. E. Turbett, and E. P. Hyle.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-24
Description: Concerns about false-negative (FN) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) have prompted recommendations for repeat testing if suspicion for coronavirus disease 2019 (COVID-19) infection… -
Creator: the Siren Study Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-09
Description: Increased understanding of whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We aimed to investigate whether antibodies against SARS-CoV-2 were associated with a decreased… -
Creator: Frampton, Dan, Tommy Rampling, Aidan Cross, Heather Bailey, Judith Heaney, Matthew Byott, Rebecca Scott, Rebecca Sconza, Joseph Price, Marios Margaritis, Malin Bergstrom, Moira J. Spyer, Patricia B. Miralhes, Paul Grant, Stuart Kirk, Chris Valerio,…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-04-12
Description: Emergence of variants with specific mutations in key epitopes in the spike protein of SARS-CoV-2 raises concerns pertinent to mass vaccination campaigns and use of monoclonal antibodies. We aimed to describe the emergence of the B.1.1.7 variant of… -
Creator: NETEC
Subject: Elementos en Español
Item Type: Guide
Date Last Updated: 2021-02-02
Description: This printable flyer infographic is a Spanish language version of "COVID-19 Testing 101." It shows the types of tests available for COVID-19 and their differences. -
Creator: Garibaldi, Brian T., Kunbo Wang, Matthew L. Robinson, Scott L. Zeger, Karen Bandeen-Roche, Mei-Cheng Wang, G. Caleb Alexander, Amita Gupta, Robert Bollinger, and Yanxun Xu.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2021-03-01
Description: Clinical effectiveness data on remdesivir are urgently needed, especially among diverse populations and in combination with other therapies. -
Creator: Brenner, Daniel S., Gigi Y. Liu, Rodney Omron, Olive Tang, Brian T. Garibaldi, and Tiffany C. Fong.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-03-01
Description: As medical infrastructures are strained by SARS-CoV-2, rapid and accurate screening tools are essential. In portions of the world, reverse transcription polymerase chain reaction (RT-PCR) testing remains slow and in limited supply, and computed… -
Creator: NETEC
Subject: Laboratory
Item Type: Webinar
Date Last Updated: 2021-02-24
Description: In this webinar, we will discuss the diagnostics related to saliva testing and how it compares to nasal swabs for COVID-19 screening, describe novel saliva testing technology including the SalivaDirect process for testing people suspected of… -
Creator: Ignatius, Elisa H., Kunbo Wang, Andrew Karaba, Matthew Robinson, Robin K. Avery, Paul Blair, Natasha Chida, Tania Jain, Brent G. Petty, Zishan Siddiqui, Michael T. Melia, Paul G. Auwaerter, Yanxun Xu, and Brian T. Garibaldi.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-12-28
Description: Background: There is currently no single treatment that mitigates all harms caused by severe acute respiratory syndrome coronavirus 2 infection. Tocilizumab, an interleukin-6 antagonist, may have a role as an adjunctive immune-modulating therapy. -
Creator: The RECOVERY Collaborative Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-02
Description: Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.A response to this article was…